Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 75/100

Rigel to Present at the Jefferies Global Healthcare Conference

Thursday, May 30, 2024 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. has announced that its CEO, Raul Rodriguez, will present a company overview at the Jefferies Global Healthcare Conference on June 6, 2024. This event is critical as it provides an opportunity for the company to showcase its innovations in therapies for hematologic disorders and cancer. Attendees can access the presentation through the company's website, highlighting Rigel's commitment to transparency and stakeholder engagement.

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals is presenting at a major healthcare conference.
  • The presentation may enhance visibility for Rigel's innovative therapies.
  • Raul Rodriguez, the company's CEO, will be discussing company developments.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., May 30, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:30 am ET in New York, NY.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
Email: [email protected]
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When is Rigel Pharmaceuticals' presentation at the Jefferies Conference?

Rigel Pharmaceuticals' presentation will be on June 6, 2024, at 9:30 am ET.

How can I access Rigel's live webcast?

You can access the webcast through the Investor Relations section of Rigel's website.

What is Rigel Pharmaceuticals dedicated to?

Rigel focuses on developing therapies for hematologic disorders and cancer.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals healthcare conference Raul Rodriguez biotechnology
Last updated: May 30, 2024

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London